Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › pheochromocytoma

Pheochromocytoma

Part of Germ cell tumors

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for pheochromocytoma

7 trials tracked for pheochromocytoma: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 183 citations.

7Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 6
  1. Phase 3 Preoperative Alpha Blockade for Pheochromocytoma Completed · 183 cited
  2. Phase 2 Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study Completed
  3. Phase 2 Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma Completed
  4. Phase 2 A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors Completed
  5. Phase 2 A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... Completed
  6. Phase 2 Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma Completed
Show 1 more trials
  1. Phase 2 Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Radiomics and deep learning provide promising tools for precise assessment of adrenal masses
Diabetes & Endocrinology Sys. Review
Radiomics and deep learning provide promising tools for precise assessment of adrenal masses AI and radiomics show promise for adrenal tumor diagnosis
This systematic review evaluates the utility of radiomics and deep learning (DL) techniques in assessing adrenal masses including pheochromo…
A new review finds AI-powered imaging analysis could improve how doctors diagnose adrenal masses, but clinical use is still far off.
Frontiers Jul 30, 2026
SDHD Variant Carriers Face High Penetrance and Multifocal Tumors
Oncology Meta-analysis
SDHD Variant Carriers Face High Penetrance and Multifocal Tumors SDHD Genetic Variants Linked to Increasing Risk of Tumors Over Time
A meta-analysis of SDHD pathogenic variant carriers reveals age-specific penetrance rising to 82% by age 60, with 75% developing multifocal …
New data shows that the risk of developing tumors increases significantly with age for people carrying specific SDHD genetic variants.
Jul 26, 2026
Laryngeal obstruction as initial sign of MEN2B in two pediatric cases with RET mutations
Diabetes & Endocrinology Sys. Review
Laryngeal obstruction as initial sign of MEN2B in two pediatric cases with RET mutations Rare genetic disorder first shows as breathing trouble in children
This case report describes 2 pediatric patients with MEN2B presenting with laryngeal obstruction and progressive respiratory compromise as i…
Two children with a rare genetic condition first showed breathing trouble from nerve growths in the airway, not the usual symptoms.
Frontiers Jul 25, 2026
Concurrent primary aldosteronism and micro-pheochromocytoma can coexist in patients with paroxysmal hypertension
Nephrology Sys. Review
Concurrent primary aldosteronism and micro-pheochromocytoma can coexist in patients with paroxysmal hypertension Surgery helps woman with complex high blood pressure and tumors
This case report describes a 65-year-old woman with paroxysmal hypertension who presented with concurrent primary aldosteronism and a micro-…
A 65-year-old woman found to have two different types of adrenal gland issues was successfully treated after surgery.
Frontiers Jul 24, 2026
Pheochromocytoma misdiagnosed as allergic vasculitis in a 36-year-old male led to ulcer healing but required toe amputation
Diabetes & Endocrinology Sys. Review
Pheochromocytoma misdiagnosed as allergic vasculitis in a 36-year-old male led to ulcer healing but required toe amputation 24 Years of Leg Ulcers Led Back to a Hidden Tumor
This case report describes a 36-year-old male with pheochromocytoma initially misdiagnosed as allergic vasculitis.
A man's 24-year leg ulcer mystery ended when a hidden adrenal tumor was found, proving the wrong diagnosis kept his wounds from healing.
Frontiers Apr 13, 2026